Morpholino

MO6-dysf

ID
ZDB-MRPHLNO-201109-1
Name
MO6-dysf
Previous Names
None
Target
Sequence
5' - GAAACCTGCAAACATACACAAAGGC - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO6-dysf
Expressed Gene Anatomy Figures
dysf Fig. 7 with image from Ono et al., 2020
Phenotype
Phenotype resulting from MO6-dysf
Phenotype Fish Figures
myotome skeletal muscle fiber development decreased process quality, abnormal AB + MO6-dysf Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle myofibril disorganized, abnormal AB + MO6-dysf Fig. 7 with image from Ono et al., 2020
whole organism dysf expression decreased amount, abnormal AB + MO6-dysf Fig. 7 with image from Ono et al., 2020
Phenotype of all Fish created by or utilizing MO6-dysf
Phenotype Fish Conditions Figures
whole organism dysf expression decreased amount, abnormal AB + MO6-dysf standard conditions Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle myofibril disorganized, abnormal AB + MO6-dysf standard conditions Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle fiber development decreased process quality, abnormal AB + MO6-dysf standard conditions Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle myofibril organization quality, ameliorated AB + MO6-dysf chemical treatment by environment: metformin Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle myofibril organization quality, ameliorated AB + MO6-dysf chemical treatment by environment: AICA ribonucleotide Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle fiber development process quality, ameliorated AB + MO6-dysf chemical treatment by environment: AICA ribonucleotide Fig. 7 with image from Ono et al., 2020
myotome skeletal muscle fiber development process quality, ameliorated AB + MO6-dysf chemical treatment by environment: metformin Fig. 7 with image from Ono et al., 2020
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.